Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
236 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (1)
  • (-) Closed (1)

Medical Condition

  • Show all (231)
  • Addiction (2)
  • Autoimmune Disorders (1)
  • Blood Disorders (1)
  • Cancer (27)
  • Endocrine & Metabolic Disease (1)
  • Eye (1)
  • Healthy Volunteers (25)
  • Heart Disease (1)
  • Neurological Disorders (134)
  • Pediatrics (9)
    • Cancer (6)
      • (-) Pediatric Solid Tumors (1)
    • Neuromuscular (1)
  • Psychiatric Disorders (26)
  • Stroke (1)
  • Transplant (1)
  • Vascular Conditions (1)
Displaying 1 - 1 of 1

Study of Entrectinib in Children and Adolescents with Solid Tumors and Primary CNS Tumors

Condition: Cancer / Pediatric Solid Tumors
Investigator: Stergios Zacharoulis, MD
Status: Closed
The purpose of this study is to find out more about how the study drug called entrectinib will be used in children, adolescents and young adults with treatment-resistant solid tumor in brain or body. This is a phase 1/1b study, divided into a dose escalation portion (different dose will be tested) and a dose expansion portion…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science